Our Clinic
At Solasta we are passionate about quality – for the quality of the product we replace your natural lens with and the quality of life after your operation.
Alcon is the largest eye care device company in the world. Alcon operate in the ophthalmic surgical and vision care markets, which are large, dynamic and growing. A global leader in quality and leading the way with real-world clinical data.
Alcon has a large choice of dioptres for all your visual requirements and can provide toric and multi-focal (Pan Optic) lenses too.
Our world class facilities use Alcon’s machines and consumables - a comprehensive portfolio of superb products.
For any further information, our team will talk you through it in your consultations.
Alcon® has been helping people see better since 1947 and Alcon’s intraocular lenses (IOL) for cataract surgery are the most widely implanted lenses in the world.
Since 1994, over 100 million people have had their sight restored and improved with an Alcon IOL.
Solasta Healthcare use Alcon’s UltraSert® for their cataract patients.
This is Alcon’s most trusted and most widely implanted AcrySof® brand lens that is preloaded into a delivery system for your surgeon to use.
Preloading means there is a lower risk of damage to the lens through handling and manual loading and also the added confidence of absolute sterility as the lens is never exposed to the air.
This makes the procedure more efficient and smoother for your surgical team, helping to make your surgery straightforward and even a little shorter.
You should aim to have your eyes tested every two years to spot symptoms of cataracts early.
The AcrySof platform range of lenses from Alcon have been specifically designed to improved visual clarity and image quality after cataract surgery.
All lenses have a UV filter contained within the material for ocular protection but your surgeon may also recommend a model with an additional blue light filter that may assist in protecting the eye from the effects of exposure to harmful short wavelength light.
Last year, following an audit of the National Ophthalmology Database, The Royal College of Ophthalmologists published a report titled ‘Feasibility study of Post-cataract Capsule Opacification 2021”.
This was the largest ever audit of cataract procedures; more than 600k procedures carried out by over 2.5k surgeons were reviewed.
The data considered Posterior Capsular Opacification (PCO) to identify factors that influence variance in rates.
The data suggests a strong association between the intraocular lens (IOL) used and PCO rates.
Finally, of all available cataract replacement lenses available today, AcrySof’s unique design and lens material have been proven to have the lowest rates of post-operative complications.
Book a consultation and let’s see if now’s the right time for cataract surgery
Patient Reviews